Position in BMY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$567,685,607
+$30,607,902 QoQ
Shares Held
9,852,232
+11.3% QoQ
Ownership
0.482%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#33
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 62%
Shared 0%
None 38%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LSV ASSET MANAGEMENT holds $2,451,058,699 across 9 Drug Manufacturers - General names. BMY ranks #2 (23.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
5,299,408 | $680,973,928 | |
| 2 | BMY |
Bristol Myers Squibb Co
This page
|
9,852,232 | $567,685,607 | |
| 3 | PFE |
Pfizer Inc
|
18,940,504 | $456,087,336 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,635,721 | $332,996,991 | |
| 5 | AMGN |
Amgen Inc
|
603,549 | $218,557,163 | |
| 6 | BIIB |
Biogen Inc.
|
444,049 | $95,941,226 | |
| 7 | OGN |
Organon & Co.
|
3,737,036 | $50,599,467 | |
| 8 | JNJ |
Johnson & Johnson
|
184,693 | $46,906,481 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $567,685,607 | 9,852,232 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $537,077,705 | 8,855,362 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $466,731,438 | 8,652,789 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $372,953,187 | 8,269,472 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $376,400,330 | 8,131,353 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $495,023,688 | 8,116,473 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $470,534,970 | 8,319,218 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $442,133,356 | 8,545,291 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $343,905,984 | 8,280,905 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $462,703,429 | 8,532,241 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $448,216,606 | 8,735,463 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $522,172,124 | 8,996,763 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $601,043,987 | 9,398,655 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $651,613,529 | 9,401,436 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $679,556,022 | 9,444,837 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $705,174,055 | 9,919,455 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $768,171,481 | 9,976,253 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $747,611,469 | 10,237,046 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $633,528,935 | 10,160,849 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $619,716,344 | 10,473,489 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $711,275,045 | 10,644,643 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $666,357,540 | 10,555,323 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $688,507,443 | 11,099,588 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $697,965,392 | 11,576,802 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $665,821,270 | 11,323,491 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $544,568,707 | 9,769,801 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||